Science
Mechanism of Action
Apigenin operates through a five-fold pathway: it neutralizes oxidative stress by boosting endogenous enzymes, suppresses pro-inflammatory cytokines like IL-31, and reinforces the skin barrier by upregulating filaggrin and lipid synthesis. At the structural level, it activates the Smad2/3 signaling pathway to induce collagen I and III production while inhibiting MMP-1 enzymes that degrade the dermal matrix.
Research
Clinical Evidence
High confidence1%
Key findings
- 01 A 10% topical application demonstrated significant increases in dermal density and elasticity with a measurable reduction in wrinkle depth over 8 weeks.
- 02 Low-concentration application (0.1%) showed a marked improvement in epidermal barrier homeostasis and lamellar body formation in murine models.
- 03 In vitro analysis confirms dose-dependent stimulation of collagen synthesis in human dermal fibroblasts between 5-25 μM without cellular toxicity.
Transparency
Dusting Analysis
Because Apigenin is effective at very low concentrations (0.1%) for barrier repair, brands often include it at 'label-only' levels (below 0.05%) to claim its benefits without achieving the thresholds required for significant collagen induction or visible anti-aging results.
The Formula
Formulation
Stability
Highly sensitive to alkaline environments; degradation occurs rapidly above pH 5.5. Most stable at an acidic pH of 3.0.
Synergies
- Glycols
- Liposomes
- Ethosomes
- Oleic Acid
Conflicts
- Strong alkaline environments
- High-heat processing
- Aqueous-only systems without delivery enhancers
Safety
Safety Profile
While the pure isolate is pending CIR review, its parent extracts (Chamomile/Barley) are categorized as 'Safe as Used.' Clinical data at 10% indicates excellent skin tolerance.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-precision bioactive that excels in anti-aging and barrier repair when formulated in acidic, lipid-based delivery systems.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources